Abstract：
To answer the increased demand for augmentation rhinoplasty, particularly in Asian demographics, a shift from autogenous materials to synthetic implants like silicone and expanded polytetrafluoroethylene has been witnessed. These materials present an increased risk of complications like infection, extrusion, capsular contracture, and dissatisfaction. This study focuses on a case of revision rhinoplasty in a 48-year-old patient with a previous silicone implant and propose an innovative approach in managing the implant capsule. The use of the existing capsule as a mechanical and biological support structure for the diced cartilage graft in dorsal reconstruction showcases a promising method to mitigate risks and improve outcomes in revision surgeries. The capsule around the silicone is biologically active and provides a good environment for the cartilage graft to survive and improve the healing process. This approach tends to minimize the dissection to avoid potential revision complications like skin necrosis, fibrotic tissue, and infections.
摘要：
为了应对隆鼻需求的增加，特别是在亚洲人口统计学中，已经见证了从自体材料到合成植入物的转变，如有机硅和膨胀聚四氟乙烯。这些材料会增加感染等并发症的风险，挤压,包膜挛缩,和不满。这项研究的重点是一名48岁患者先前使用硅胶植入物的翻修隆鼻手术，并提出了一种管理植入物胶囊的创新方法。在背侧重建中使用现有的胶囊作为切块软骨移植物的机械和生物支持结构，展示了一种有希望的方法来减轻风险并改善翻修手术的结果。硅胶周围的胶囊具有生物活性，并为软骨移植物的存活和改善愈合过程提供了良好的环境。这种方法倾向于尽量减少解剖，以避免潜在的翻修并发症，如皮肤坏死，纤维化组织,和感染。
